CRL
Charles River Laboratories International, Inc.
NYSE · usd
Charles River Laboratories International, Inc. (CRL) trades at $335.52 (-0.72%) as of 6:30:00 PM EST on Nov 16, 2026, +11.78% over the past month. Market cap is $16.19B, with 2.2 days to cover in short interest.
Stock performance
How Charles River Laboratories International, Inc. (CRL) stock has performed from one day to one year, with its 52-week range.
- 1D
- -0.72%
- 1W
- -5.04%
- 1M
- +11.78%
- YTD
- +68.20%
- 1Y
- +106.17%
- 52-wk range
- $146.20 – $379.63
Key statistics
Today's trading snapshot for CRL: day range, open, previous close, volume and market cap.
- Day range
- $328.68 – $338.20
- Open
- $334.13
- Prev close
- $337.97
- Volume
- 693.58K
- Market cap
- $16.19B
- Shares out
- 47.92M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Charles River Laboratories International, Inc.: P/E, P/S, P/B, ROE and more.
- P/E
- 402.98
- P/S
- 4.07
- P/B
- 5.02
- P/FCF
- 60.11
- ROE
- 1.3%
- ROA
- 0.5%
- Debt/Equity
- 0.76
- Div yield
- 0.00%
As of Nov 13, 2026
8-K filings
Material corporate events Charles River Laboratories International, Inc. has disclosed to the SEC on Form 8-K.
- Acquisition agreementNov 9, 2026
On November 9, 2026, Charles River Laboratories International, Inc. ("Charles River") issued a press release announcing that it has entered into definitive agreements to acquire Frontage Holdings Corporation's bioanalysis and DMPK operations in Exton, Pennsylvania.
- Quarterly earningsNov 4, 2026
On November 4, 2026, Charles River Laboratories International, Inc. issued a press release providing financial results for the third quarter ended September 26, 2026.
- Investor presentationSep 24, 2026
On September 24, 2026, in connection with its Investor Day, Charles River Laboratories International, Inc. (the "Company") issued a press release... The Company will host its Investor Day beginning at 9:00 a.m. Eastern time today, which will be live webcast and archived on the Company's Investor Relations website. To access the webcast and corresponding slide presentation, visit http://ir.criver.com.
- Annual meeting resultsMay 11, 2026
At the Company's Annual Meeting, the following proposals were adopted by the votes specified below. (a) The following twelve (12) directors were elected to serve until our 2027 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below.
- Guidance issuance or updateFeb 25, 2026
The Company is updating its financial guidance for 2026, which was initially provided on February 18, 2026, for the impact of the planned divestitures. The updated financial guidance assumes both transactions close during the second quarter of 2026. The planned divestitures are expected to reduce reported revenue by slightly more than $200 million in 2026, including more than a 50-basis-point reduction to organic revenue growth guidance.
CRL short interest
How heavily CRL is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 2.2
- Short interest
- 2.99M
- Avg volume
- 1.34M
As of · reported to FINRA twice monthly.
CRL news
The latest news and headlines about Charles River Laboratories International, Inc. (CRL).
- GMRS vs. CRL: Which Stock Should Value Investors Buy Now?positiveZacks Investment Research· Nov 12, 2026
- Here's Why Charles River Laboratories (CRL) is a Strong Momentum StockpositiveZacks Investment Research· Nov 9, 2026
- Charles River Q3 Earnings & Revenues Top Estimates, Stock RisespositiveZacks Investment Research· Nov 4, 2026
- Revvity (RVTY) Tops Q3 Earnings and Revenue EstimatesneutralZacks Investment Research· Nov 3, 2026
- Charles River's Q3 Earnings on Deck: What's in Store for the Stock?neutralZacks Investment Research· Nov 2, 2026
Frequently asked questions
What is the Charles River Laboratories International, Inc. (CRL) stock price today?
Charles River Laboratories International, Inc. (CRL) is trading at $335.52 (-0.72% on the day) as of 6:30:00 PM EST on Nov 16, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Charles River Laboratories International, Inc.?
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models…
What is the short interest in CRL?
As of Oct 30, 2026, CRL has 2.99M shares short and 2.2 days to cover.
What exchange is CRL listed on?
Charles River Laboratories International, Inc. (CRL) trades on NYSE in USD, in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry.
Build with AI
Build an analysis of CRL with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a CRL analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.